Arquer Diagnostics

We are Arquer Diagnostics, a dynamic, female-led and UK-based company working at the cutting-edge of cancer diagnostics. It is our mission to transform how patients are diagnosed with cancer and then monitored throughout their treatment journey. We are doing this by developing and commercialising quick, simple, non-invasive, accurate and cost-effective cancer biomarker tests. We believe no one should have to undergo unnecessary invasive and painful procedures. Our tests are based on more than 20 years' research and use patented technology to diagnose and monitor bladder, endometrial, prostate and ovarian cancers by detecting the cancer biomarker MCM5 (Minichromosome Maintenance Complex Component 5) from a simple urine sample.

• Employees 3
• Founded 2006
• Annual Revenue $7000000
• Total Funding $6616899